Luo-Qi Zhou

Huazhong University of Science and Technology

H指数:22

被引数:8,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diet and the Risk of Multiple Sclerosis: Evidence With UK Biobank Nested Case–Control Study and Mendelian Randomization Analysis

饮食与多发性硬化症风险：基于英国生物银行巢式病例对照研究和孟德尔随机化分析

Molecular Nutrition & Food Research

IF4.2

2025-11-210

OAAI

Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis

进行性多发性硬化患者的抗BCMA car-t治疗

Cell

IF42.5

2025-10-150

OAAI

Identification of novel therapeutic targets for cognitive performance and associations with brain health

识别认知表现的新治疗靶点及其与脑健康的关系

Translational Psychiatry

IF6.2

2025-06-250

OAAI

Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy

抗BCMA CAR-T细胞疗法在复发/难治性慢性炎症性脱髓鞘多发性神经病中的应用

Med

IF11.8

2025-05-260

OAAI

The foam cell-derived exosomes exacerbate ischemic white matter injury via transmitting metabolic defects to microglia

泡沫细胞来源的exosomes通过向小胶质细胞传递代谢缺陷，加剧缺血性白质损伤。

Cell Metabolism

IF30.9

2025-05-080

PRE

Circulating insulin-like growth factor-1 and the risk of multiple sclerosis: a prospective cohort study

循环胰岛素样生长因子-1与多发性硬化风险：一项前瞻性队列研究

MULTIPLE SCLEROSIS AND RELATED DISORDERS

IF2.9

2025-02-010

PRE

Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway

JOURNAL OF NEUROINFLAMMATION

IF10.1

2024-11-080

OAAI

The foam cell-derived exosomal miRNA Novel-3 drives neuroinflammation and ferroptosis during ischemic stroke

泡沫细胞来源的囊泡miRNA Novel-3在缺血性脑卒中期间驱动神经炎症和铁死亡。

NATURE AGING

IF19.4

2024-10-285

PRE

Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke

系统性药物全基因组孟德尔随机化确定缺血性卒中后功能结局的治疗靶点

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2024-08-200

OAAI

Ldl-stimulated microglial activation exacerbates ischemic white matter damage

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2024-07-013

PRE

Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity

SCIENCE IMMUNOLOGY

IF16.3

2024-05-104

Dawn of CAR-T cell therapy in autoimmune diseases

CHINESE MEDICAL JOURNAL

IF7.3

2024-04-121

OAAI

B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis

EMBO MOLECULAR MEDICINE

IF8.3

2024-02-2610

OAAI

Causal association between the peripheral immunity and the risk and disease severity of multiple sclerosis

外周免疫与多发性硬化症的风险和疾病严重程度之间的因果关系

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-081

OAAI

Single- cell analysis of refractory anti- SRP necrotizing myopathy treated with anti- BCMA CAR- T cell therapy

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-01-3016

OAAI

Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder

NEUROSCIENCE BULLETIN

IF5.8

2024-01-161

OAAI

TREM2-IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke

TREM2-IGF1介导的糖代谢增强是缺血性卒中小胶质细胞神经保护特性的基础

ADVANCED SCIENCE

IF14.1

2023-12-274

OAAI

Anti-BCMA CAR T-CELL therapy CT103A in relapsed or refractory AQP4-IGG seropositive neuromyelitis optica spectrum disorders: Phase 1 trial interim results

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2023-12-010

PRE

Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders

BRAIN

IF11.7

2023-09-2210

PRE

Research hotspots and trends on neuromyelitis optica spectrum disorders: insights from bibliometric analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-131

OAAI

Luo-Qi Zhou

个人简介

教育背景

工作经历

荣誉奖项

研究方向